Viral Vector Manufacturing Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025
Report Description
Global Viral Vector Manufacturing Market is expected to grow at a CAGR of 17.6% from 2016 to 2025.The report highlights the key trends, market outlook and the global scenario of the Global Viral Vector Manufacturing Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market.
The major key players of the market are as follows:
KEY PLAYERS
ADVANCED BIOSCIENCE LABORATORIES, INC.
ADVANCED BIOTHERAPEUTICS CONSULTING
APPLIED VIROMICS
BATAVIA BIOSCIENCES
BENITEC BIOPHARMA
BIOGEN IDEC (NOW BIOGEN, INC.)
BIOVIAN
BOEHRINGER INGELHEIM GMBH
BRAMMER BIO
CELL AND GENE THERAPY CATAPULT
CEVA CORPORATE
COBRA BIOLOGICS (SUBSIDIARY OF RECIP AB)
CREATIVE BIOGENE
GE HEALTHCARE
GENEDETECT
GENVEC INC. (SUBSIDIARY OF INTREXON CORP.)
ID PHARMA CO. LTD.
JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON
LONZA
MERCK MILLIPORE
MILTENYI BIOTEC
MOLMED SPA
PARAGON BIOSERVICES INC.
PFIZER INC.
SANOFI
SEMENTIS
SPARK THERAPEUTICS INC.
SYNPROMICS
VALNEVA
VECTOR BIOLABS
VIGENE BIOSCIENCES INC.
VIROVEK
Scope of the Market
Type Market
Adenoviral Vectors
Retroviral Vectors
Lentiviral Vectors
Adeno-associated Viral Vectors
Cytomegalovirus
Pox Virus
Other Viral Vectors
Disease Application Market
Human Disease Applications
Veterinary Disease Applications
Application Type Market
Multivalent Viral Vector Vaccines
Multipathogen Viral Vector Vaccines
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW)
Payment Options